Literature DB >> 7778165

Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation.

Y Matsumura1, A Marchevsky, X J Zuo, R M Kass, J M Matloff, S C Jordan.   

Abstract

Lung transplantation is now routinely performed for a wide range of end-stage cardiopulmonary disorders. Despite overcoming the problems associated with early acute rejection, chronic rejection (CR) in the form of obliterative bronchiolitis has emerged as the primary cause of late graft loss. The mechanisms involved in the development of CR of lung allografts are poorly understood, and no effective therapy is currently available. To better understand the pathological events associated with CR and tolerance, we examined two models of lung allograft rejection established in our laboratory. First, we exchanged left lung allografts between moderately histoincompatible inbred rat strains (WKY-->F344: n = 42 and F344-->WKY: n = 40). The WKY-->F344 model was previously shown to develop spontaneous tolerance, while the converse model (F344-->WKY) showed persistent acute rejection. The purpose of this investigation was to assess histopathological changes associated with long-term grafts left in place up to 140 days after transplant. To confirm that tolerance had developed, skin-grafting experiments were performed. Five skin grafts from each strain were placed on lung allograft recipients on day 35 after transplant and skin allograft survival was assessed and compared with controls. Acute rejection (AR) was graded histologically (stage O-IV) and the pathologic intensity of inflammation and CR were graded (0-4: 0 = 0%, 1 = 1-25%, 2 = 26-50%, 3 = 51-75%, and 4 = 76-100%) on percentage of involvement with the following categories being examined: (a) lymphocytic infiltration (perivascular, peribronchial, and peribronchiolar) and (b) vasculitis, edema, hemorrhage, and necrosis. Finally, chronic rejection was diagnosed by the presence of intimal hyperplasia, interstitial fibrosis, peribronchiolar fibrosis, bronchiolitis obliterans, and bronchiectasis. The WKY-->F344 animals showed progressive AR (stage III, day 21). Thereafter, the AR subsided spontaneously and was stage 0 on day 140. There were no signs of CR in these animals. In the F344-->WKY model, the AR progressed up to stage III-IV (day 21) and maintained for several weeks at stage III. Thereafter, pictures of the lungs showed CR on days 49, 70, and 98. There were significant differences between the two models during the chronic phase, such as interstitial fibrosis (0 +/- 0 vs. 1.8 +/- 1.3, P < 0.005), peribronchiolar fibrosis (0 +/- 0 vs. 3.6 +/- 0.55, P < 0.01), vasculitis (0.2 +/- 0.45 vs. 2.0 +/- 0, P < 0.008), and intimal hyperplasia (0.2 +/- 0.45 vs. 2.6 +/- 0.9, P < 0.008).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7778165

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance.

Authors:  V Subbotin; H Sun; A Aitouche; L A Valdivia; J J Fung; T E Starzl; A S Rao
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

2.  Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.

Authors:  W Chalermskulrat; K P McKinnon; W J Brickey; I P Neuringer; R C Park; D G Sterka; B R Long; P McNeillie; R J Noelle; J P Ting; R M Aris
Journal:  Thorax       Date:  2005-10-27       Impact factor: 9.139

3.  Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.

Authors:  Shinji Nakashima; T Rinda Soong; Karen Fox-Talbot; Zhiping Qian; Salma Rahimi; Barbara A Wasowska; Charles A Rohde; Sabrina Chen; Joe G N Garcia; William M Baldwin
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

Review 4.  Animal models for bronchiolitis obliterans syndrome following human lung transplantation.

Authors:  Elbert Kuo; Ankit Bharat; Sekhar Dharmarajan; Felix Fernandez; G Alec Patterson; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Ferret lung transplant: an orthotopic model of obliterative bronchiolitis.

Authors:  H Sui; A K Olivier; J A Klesney-Tait; L Brooks; S R Tyler; X Sun; A Skopec; J Kline; P G Sanchez; D K Meyerholz; N Zavazava; M Iannettoni; J F Engelhardt; K R Parekh
Journal:  Am J Transplant       Date:  2012-12-03       Impact factor: 8.086

6.  Rattus model utilizing selective pulmonary ischemia induces bronchiolitis obliterans organizing pneumonia.

Authors:  John C Densmore; Paul M Jeziorczak; Anne V Clough; Kirkwood A Pritchard; Breana Cummens; Meetha Medhora; Arjun Rao; Elizabeth R Jacobs
Journal:  Shock       Date:  2013-03       Impact factor: 3.454

Review 7.  Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients.

Authors:  Rogerio Pazetti; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 8.  Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?

Authors:  Masaaki Sato
Journal:  Ann Transl Med       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.